Suppr超能文献

半乳糖凝集素介导的人卵巢癌A121细胞黏附及细胞半乳糖凝集素结合糖蛋白的检测

Galaptin-mediated adhesion of human ovarian carcinoma A121 cells and detection of cellular galaptin-binding glycoproteins.

作者信息

Skrincosky D M, Allen H J, Bernacki R J

机构信息

Department of Experimental Therapeutics, Roswell Park Cancer Institute, Buffalo, New York 14263.

出版信息

Cancer Res. 1993 Jun 1;53(11):2667-75.

PMID:8347196
Abstract

Previously, we have shown that galaptin, an endogenous beta-galactoside-binding lectin, is present in extracellular matrix where it may participate in the adhesion of A121 human ovarian carcinoma cells to extracellular matrix via interaction with specific cell surface carbohydrate receptors. We now report that A121 cells adhere to polystyrene plates coated with polymerized human splenic galaptin. The carbohydrate-mediated specificity of this adhesive interaction was demonstrated by inhibition with lactose. Additionally, treatment of A121 cells with neuraminidase increased cellular adherence by 30%, while beta-galactosidase treatment of cells decreased adherence by 65%. These findings prompted us to isolate and identify the cell surface galaptin receptor. In a Western blot of A121 cell extracts separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, 125I-labeled polymerized galaptin bound [corrected] to a unique cellular protein having a molecular mass of 110 kDa. This receptor was enriched by affinity chromatography using polymerized galaptin-Sepharose. Treatment of this material with N-glycanase ablated its galaptin-binding activity. In related studies, A121 cells metabolically labeled with [3H]glucosamine demonstrated a radiolabeled polymerized galaptin-binding protein with an identical molecular mass of 110 kDa. These studies confirmed the glycoprotein nature of this putative endogenous cellular galaptin receptor. Further studies with antibodies directed against two lysosomal associated membrane proteins, lamp-1 and lamp-2, demonstrated specific reactivity in Western blots with the 110-kDa glycoprotein. Additionally, 125I-polymerized galaptin recognized a 110-kDa protein in Western blots of material immunoprecipitated from A121 cell lysates by lamp-1 and lamp-2 antibodies. Finally, indirect immunofluorescence using antibodies directed against lamps detected cell surface antigenicity. Therefore, lamp-1 and/or lamp-2 appear to be the putative cell surface receptors involved in the adhesion of ovarian carcinoma cells to extracellular matrix mediated by galaptin.

摘要

此前,我们已经表明,半乳糖凝集素是一种内源性β-半乳糖苷结合凝集素,存在于细胞外基质中,它可能通过与特定细胞表面碳水化合物受体相互作用,参与A121人卵巢癌细胞与细胞外基质的黏附。我们现在报告,A121细胞可黏附于涂有聚合人脾半乳糖凝集素的聚苯乙烯平板上。乳糖抑制实验证明了这种黏附相互作用的碳水化合物介导特异性。此外,用神经氨酸酶处理A121细胞可使细胞黏附增加30%,而用β-半乳糖苷酶处理细胞则使黏附减少65%。这些发现促使我们分离并鉴定细胞表面半乳糖凝集素受体。在通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分离的A121细胞提取物的蛋白质免疫印迹中,125I标记的聚合半乳糖凝集素与一种分子量为110 kDa的独特细胞蛋白结合。使用聚合半乳糖凝集素-琼脂糖亲和层析可富集该受体。用N-聚糖酶处理该物质可消除其半乳糖凝集素结合活性。在相关研究中,用[3H]葡萄糖胺进行代谢标记的A121细胞显示出一种分子量相同为110 kDa的放射性标记的聚合半乳糖凝集素结合蛋白。这些研究证实了这种假定的内源性细胞半乳糖凝集素受体的糖蛋白性质。用针对两种溶酶体相关膜蛋白lamp-1和lamp-2的抗体进行的进一步研究表明,在蛋白质免疫印迹中,这些抗体与110 kDa糖蛋白有特异性反应。此外,125I-聚合半乳糖凝集素在由lamp-1和lamp-2抗体从A121细胞裂解物中免疫沉淀的物质的蛋白质免疫印迹中识别出一种110 kDa的蛋白。最后,使用针对lamp的抗体进行间接免疫荧光检测到细胞表面抗原性。因此,lamp-1和/或lamp-2似乎是参与半乳糖凝集素介导的卵巢癌细胞与细胞外基质黏附的假定细胞表面受体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验